Daniel Mikula

Daniel is responsible for managing the overall activities of the Rare Disease Research Catalyst Consortium (RDCat). His primary focus is to support a group of Irish-based healthcare professionals, researchers and patients working in collaboration to increase rare disease research in Ireland.  In his role, he liaises with national and international stakeholders to support the delivery of objectives aiming to build rare disease excellence with a special focus on Patient and Public Involvement (PPI).  

Daniel has more than 10 years of healthcare experience. He has worked on rare disease clinical trials and disease registries as a research nurse.  He has completed a Masters degree in Clinical and Translational Research.